Manufacturer of non-invasive transcranial magnetic stimulation (TMS) systems for research, diagnostics and therapy.
MagVenture A/S
Denmark (HQ) · Alpharetta, GA, USA · United Kingdom · Germany · Brazil · ChinaNew on Amplifa
About MagVenture
MagVenture is a private Danish medical technology company and manufacturer of non-invasive transcranial magnetic stimulation (TMS) systems. The company develops, produces and quality-checks its products in Denmark, with manufacturing carried out exclusively by Tonica AS. The product range includes research and diagnostic systems, clinical TMS therapy systems such as the MagPro R20 and R30 portfolio, and the portable system MagVenture Go™ (TMS and magnetic peripheral nerve stimulation, mPNS), based on the MagPro® R20 platform. The systems are used in psychiatry, neurology, neurophysiology, cognitive neuroscience and rehabilitation, including the treatment of depression and obsessive-compulsive disorder (OCD). Sales are handled through direct subsidiaries in the USA, Germany, the UK, Brazil and China as well as a distributor network in more than 70 countries. In addition, MagVenture offers training and clinical TMS certification courses as well as service and support.
- Site
- Alpharetta, GA, USA
- Processes
- Training and TMS certification courses, Service and support, Sales via subsidiaries and distributors
- Materials
- Transcranial Magnetic Stimulation, Magnetic Peripheral Nerve Stimulation, Accelerated TMS Protocols
- Founded
- 1992
- Industries
- Medical Technology, Psychiatry, Neurology, Neurophysiology, Cognitive Neuroscience, Research
- 01
R&D (TMS technology)
- 02
Design and development in Denmark
- 03
Production by Tonica AS in Denmark
- 04
Quality inspection in Denmark
- 05
Sales via subsidiaries and distributors
- 06
Training, certification and service
Products & Technologies
Transcranial Magnetic Stimulation
Core method of MagVenture systems for therapy, diagnostics and research on the central and peripheral nervous system.
Magnetic Peripheral Nerve Stimulation
Complementary method for peripheral pain therapy, integrated in the MagVenture Go™ system.
Accelerated TMS Protocols
FDA-cleared protocols with multiple sessions per day, treatment durations from as little as five days.
Locations
Denmark
DKHeadquarters, development, production (Tonica AS) and quality inspection
- MagPro R20
- MagVenture Go
- R30 Therapy Package
Alpharetta, GA, USA
USUS sales and branch office
Systems & Packages
Inside the production
Industries
3 Anlagen & Maschinen
| Machine | Manufacturer / model | Quantity | Working area | Year built | Site |
|---|---|---|---|---|---|
| TMS stimulation system | MagVenture MagPro R20 | – | – | – | Denmark (production by Tonica AS) |
| Portable TMS system (TMS + mPNS, MagPro R20 platform) | MagVenture MagVenture Go | – | – | – | – |
| TMS therapy system | MagVenture R30 Therapy Package | – | – | – | – |
Additional services
Reference customers
History
- 1992
Founding and pioneering work in TMS ("Advancing TMS since 1992"); first MagPro stimulator system for brain stimulation research.
- 2026
January: Acquisition of Brain Science Tools (neuronavigation). April: Lancet publication on Magnetic Seizure Therapy. May: FDA clearance for accelerated TMS protocols and launch of MagVenture Go™ Portable. June: FDA clearance of Wave Neuroscience MeRT® for PTSD.